Infliximab
TED · 573716-2026Award noticeawardedNo deadline given
Buyer
Name—
Country—
Published2026-08-19
Deadline—
CPV codes
33652000 Medical equipment & pharmaceuticalsDescription
Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif « Infliximab ».
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-19 | Pomalidomide | — | 95% |
| 2026-09-01 | Pirfénidone | — | 95% |
| 2026-09-25 | Aflibercept | — | 94% |
| 2026-08-19 | Rituximab | — | 93% |
| 2026-07-07 | Bévacizumab | — | 92% |
| 2026-09-16 | Spécialités pharmaceutiques à base d'infliximab IV | — BE | 89% |